DIVA Laboratories Ltd (4153) - Total Liabilities

Latest as of March 2026: NT$447.40 Million TWD ≈ $14.10 Million USD

Based on the latest financial reports, DIVA Laboratories Ltd (4153) has total liabilities worth NT$447.40 Million TWD (≈ $14.10 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4153 financial resilience to evaluate the company's liquid asset resilience ratio.

DIVA Laboratories Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how DIVA Laboratories Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is DIVA Laboratories Ltd's balance sheet.

DIVA Laboratories Ltd Competitors by Total Liabilities

The table below lists competitors of DIVA Laboratories Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Grupo Mexicano de Desarrollo S.A.B MX:GMD	Mexico	MX$3.45 Billion
Nevada King Gold Corp V:NKG	Canada	CA$264.21K
TROPHY GAMES Development AS CO:TGAMES	Denmark	Dkr11.62 Million
Thinkific Labs Inc TO:THNC	Canada	CA$19.80 Million
JLS Co.Ltd KQ:040420	Korea	₩19.77 Billion
Smart Digital Group Limited Ordinary Shares NASDAQ:SDM	USA	$5.60 Million
As Commercial Industrial Company of Computers and Toys S.A. AT:ASCO	Greece	€7.19 Million
Bak Ambalaj Sanayi ve Ticaret AS IS:BAKAB	Turkey	TL2.10 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down DIVA Laboratories Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is DIVA Laboratories Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.48	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DIVA Laboratories Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DIVA Laboratories Ltd (2017–2025)

The table below shows the annual total liabilities of DIVA Laboratories Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$324.52 Million ≈ $10.22 Million	+29.84%
2024-12-31	NT$249.94 Million ≈ $7.87 Million	+18.50%
2023-12-31	NT$210.93 Million ≈ $6.65 Million	-10.48%
2022-12-31	NT$235.62 Million ≈ $7.42 Million	+20.66%
2021-12-31	NT$195.27 Million ≈ $6.15 Million	+57.05%
2020-12-31	NT$124.34 Million ≈ $3.92 Million	-26.03%
2019-12-31	NT$168.09 Million ≈ $5.30 Million	+21.05%
2018-12-31	NT$138.87 Million ≈ $4.38 Million	-45.51%
2017-12-31	NT$254.84 Million ≈ $8.03 Million	--

About DIVA Laboratories Ltd

TWO:4153 Taiwan Diagnostics & Research

Market Cap

$58.78 Million

NT$1.87 Billion TWD

Market Cap Rank

#21394 Global

#1287 in Taiwan

Share Price

NT$31.80

Change (1 day)

-0.31%

52-Week Range

NT$29.75 - NT$39.45

All Time High

NT$76.08